Stuttgart - Delayed Quote EUR

GSK PLC (GS71.SG)

17.38

+0.58

+(3.48%)

At close: April 30 at 9:31:13 PM GMT+2

GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs

GSK stock jumped Wednesday after the British drugmaker said it's "well positioned" to respond if the U.S. levies tariffs on drug imports.

Investor's Business Daily yesterday

GLAXF

GSK
GSK (LSE:GSK) Sees First Quarter Sales of £7.5 Billion and Net Income Surge

GSK (LSE:GSK) reported a significant improvement in its first-quarter earnings, with sales, net income, and earnings per share all showing promising growth. This announcement coincided with a 5.14% rise in GSK's shares over the past week. Meanwhile, broader market trends have been characterized by volatility, with the major indexes seeing declines following a weak GDP report. Despite these fluctuations, GSK's positive earnings report likely bolstered investor sentiment, helping the company to...

Simply Wall St. yesterday

GLAXF

GSK
Trending tickers: Super Micro, Starbucks, Snap, GSK and Aston Martin

The latest investor updates on stocks that are trending on Wednesday.

Yahoo Finance UK yesterday

^IXIC

HOOD

GLCNF
GSK Sales, Profit Rise on Boost from HIV, Cancer Drugs

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand in the U.S.

The Wall Street Journal yesterday

GLAXF

GSK
GSK 'well positioned' for potential tariffs after beating forecasts

GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts and dual sourcing for its medicines, but offered few details. The British drugmaker reported stronger-than-expected first-quarter results and reaffirmed its 2025 outlook, sending its shares up 3.8% by 0900 GMT. They were among the top gainers on London's FTSE 100 index, which was up 0.02%.

Reuters yesterday

GLAXF
Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca

Earnings preview of key companies reporting next week and what to look out for.

Yahoo Finance UK 6 days ago

VSCFF

GBPEUR=X

GBP=X
Shingles Vaccine Appears to Lower Dementia Risk

Mounting evidence suggests that vaccination against the varicella zoster virus—which causes chickenpox in children and triggers shingles in adults—also protects the brain. Several recent studies suggest that the vaccines reduce the risk of dementia in older adults, but key questions remain, including: How the vaccines might work to stop or delay the condition, and whether the benefit is limited to people of a certain age. The vaccines studied, Zostavax and Shingrix, both appeared to offer protection.

The Wall Street Journal 8 days ago

GLAXF

GSK
Why vaccine makers aren't worried about Trump administration cuts

Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

Yahoo Finance 4 days ago

SNY

SNYNF

GLAXF
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease

--76-week trial is evaluating the safety and efficacy of a progranulin-elevating candidate in slowing disease progression-- --Enrollment completed ahead of schedule-- SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced the completion of enrollment in PROGRESS-AD, a 76-week Phase 2 clinical trial evalu

GlobeNewswire 14 days ago

GLAXF

GSK

ALEC
AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices

PHILADELPHIA, April 16, 2025--AREXVY recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices

Business Wire 15 days ago

GLAXF

GSK
GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices

PHILADELPHIA, April 16, 2025--GSK’s 5-in-1 meningococcal vaccine PENMENVY receives positive recommendation from US Advisory Committee on Immunization Practices

Business Wire 15 days ago

GLAXF

GSK
GSK (LSE:GSK) Sees 6% Share Price Decline Over The Last Quarter

GSK (LSE:GSK) recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and the EMA's acceptance of an application for Nucala's expanded use. Despite these positive developments, the company's share price experienced a 6% decline over the last quarter. This movement occurred amid broader market volatility, where major indices faced notable declines, though recently improved following a pause on tariffs. GSK's earnings report revealed a decline...

Simply Wall St. 21 days ago

GLAXF

GSK
GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025

PHILADELPHIA, April 09, 2025--GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025

Business Wire 22 days ago

GLAXF

GSK
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca

The latest investor updates on stocks that are trending on Wednesday.

Yahoo Finance UK 22 days ago

DAL

GM

SVNDF
Spirits, Swiss Watches, Sneakers: Global Stock-Market Winners and Losers from Tariffs

Here are some notable moves across sectors in global markets, following President Trump’s “Liberation Day” tariffs. Some investors turned to drink: Scotch producer Diageo and Aperol maker Campari were among the few risers in Europe. This is mostly about their imports from Mexico and Canada, brokers say, after the White House kept duty-free access to the U.S. for USMCA-compliant products.

The Wall Street Journal 28 days ago

NKE

AZN

AZNCF
How Trump's tariffs will impact your finances and the UK economy

Keir Starmer has admitted the US president's trade war will hurt the UK economy.

Yahoo Finance UK 28 days ago

LVMHF

LVMUY

GBPEUR=X
Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out

Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger drugmakers, such as GSK, also retreated.

The Wall Street Journal last month

MRNA

SRPT

PFE
China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market

Boosted by partnerships with Big Pharma and a push into China, Veeva continues to battle to break out in troubled market.

Investor's Business Daily last month

GLAXF

GSK

VEEV
U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against Covid-19 until after the election that Trump lost to Biden.

The Wall Street Journal last month

GLAXF

GSK

PFE
ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce that APRETUDE (cabotegravir tablets and extended release injectable suspension) is now covered under the federal Non-Insured Health Benefits (NIHB) Program for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in at risk individuals who are HIV-1 negative.1

CNW Group last month

PFE

GLAXF

GSK

Performance Overview

Return	GS71.SG	FTSE 100 (^FTSE)
YTD	+7.18%	+3.96%
1-Year	-14.24%	+4.62%
3-Year	-12.08%	+12.62%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

GSK PLC (GS71.SG)

GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs

GSK (LSE:GSK) Sees First Quarter Sales of £7.5 Billion and Net Income Surge

Trending tickers: Super Micro, Starbucks, Snap, GSK and Aston Martin

GSK Sales, Profit Rise on Boost from HIV, Cancer Drugs

GSK 'well positioned' for potential tariffs after beating forecasts

Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca

Shingles Vaccine Appears to Lower Dementia Risk

Why vaccine makers aren't worried about Trump administration cuts

Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease

AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices

GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices

GSK (LSE:GSK) Sees 6% Share Price Decline Over The Last Quarter

GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025

Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca

Spirits, Swiss Watches, Sneakers: Global Stock-Market Winners and Losers from Tariffs

How Trump's tariffs will impact your finances and the UK economy

Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out

China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine

ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program

Performance Overview